94 programming-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" positions at ETH Zurich
Sort by
Refine Your Search
-
and external research groups from University of Zurich and University of St.Gallen. The ETH AI Center Fellowship program is Europe’s premier PhD program focused on advancing interdisciplinary AI
-
directly supporting those engaged in peace practice and conflict transformation processes. We are seeking someone to work as a (Senior) Program Officer in our “Culture and Religion in Mediation” Program
-
and external research groups from University of Zurich and University of St.Gallen. The ETH AI Center Fellowship program is Europe’s premier Post-Doc program focused on advancing interdisciplinary AI
-
100%, Zurich, fixed-term In our highly competitive CLS doctoral training program, fellows are co-supervised by one advisor from ETH Zurich and one from the MPI for Intelligent Systems in Stuttgart
-
research, providing training and directly supporting those engaged in peace practice and conflict transformation processes. We are seeking someone to work as a Program Officer in our “Mediation Support
-
maternity cover. The Master of Advanced Studies ETH in Management, Technology, and Economics is a long-established continuing education programme at ETH Zurich, with a strong history of management education
-
and Climate Science at ETH Zurich and the WSL-Institute for Snow and Avalanche Research SLF and will be part of the NCCR CLIM+ programme which is funded by the Swiss National Science Foundation (SNSF
-
the Aviation Transformation Programme (ATP-Airport). A consortium led by the Singapore University of Technology and Design (SUTD), with SEC, NTU, and SIT as partner institutions, will develop a compact robotic
-
regulation, electromagnetic programming of wireless expression, and closed-loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as
-
regulation, electromagnetic programming of wireless expression, and closed-loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as